Genomma Lab Internacional SAB de CV (GNMLF)
1.06
0.00 (0.00%)
USD |
OTCM |
Dec 17, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.032B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -14.41% |
| Valuation | |
| PE Ratio | 11.57 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.118 |
| Price to Book Value | 1.719 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.0109 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.6736 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 63.74% |
Profile
| Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico. |
| URL | http://www.genommalab.com |
| Investor Relations URL | https://inversionistas.genommalab.com |
| HQ State/Province | Ciudad de Mexico |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 25, 2026 (est.) |
| Last Earnings Release | Oct. 22, 2025 |
| Next Ex-Dividend Date | Dec. 22, 2025 |
| Last Ex-Dividend Date | Sep. 18, 2025 |
Ratings
Profile
| Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico. |
| URL | http://www.genommalab.com |
| Investor Relations URL | https://inversionistas.genommalab.com |
| HQ State/Province | Ciudad de Mexico |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 25, 2026 (est.) |
| Last Earnings Release | Oct. 22, 2025 |
| Next Ex-Dividend Date | Dec. 22, 2025 |
| Last Ex-Dividend Date | Sep. 18, 2025 |